Next Generation News and Research

RSS

PositiveID announces early completion of iGlucose system prototype development

PositiveID Corporation announced today that it has completed development of the initial prototype of its iGlucose system, creating a small cradle that connects to any data-capable glucose meter to automatically communicate a diabetic's blood sugar readings to the iGlucose online database.

18 May 2010

Inovio Pharmaceuticals first-quarter net loss attributable to common stockholders decreases to $2.3M

Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended March 31, 2010.

18 May 2010

Echo Therapeutics first-quarter net loss increases to $1.9 million

Echo Therapeutics, Inc., a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude™ SkinPrep System for transdermal drug delivery, today announced financial results for the period ended March 31, 2010.

18 May 2010

152 research and training grants awarded to researchers at 93 institutions nationwide

The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has awarded 152 new national research and training grants totaling $50,717,000 in the first of two grants cycles for 2010. The grants, primarily to early career researchers, cover a broad range of investigator-initiated ideas at 93 institutions nationwide, from whether cadmium exposure increases the risk of endometrial cancer, to studies of plant and bacterial-bourne compounds, to a study on a protein called survivin that could lead to novel drugs targeting prostate cancer.

18 May 2010

U.S. Patent and Trademark Office grants patent to Historx's AQUA technology

HistoRx , Inc., announced today that the U.S. Patent and Trademark Office has granted a patent protecting the company's methods for determining a cancer patient's prognosis based on sub-cellular localization of biomarkers.

15 May 2010

IVAX Diagnostics first-quarter net revenues decline 1.4% to $4,655,000

IVAX Diagnostics, Inc., a fully integrated in vitro diagnostics company, reports its financial results for the quarter ended March 31, 2010.

14 May 2010

Rensselaer professor selected to receive NSF CAREER Award

David T. Corr, assistant professor in the Department of Biomedical Engineering at Rensselaer Polytechnic Institute, has won a Faculty Early Career Development Award from the National Science Foundation.

14 May 2010

Viking Systems announces positive response to 3DHD camera-display combination at Hospital Build Asia 2010

Viking Systems, Inc. today announced an overwhelmingly positive response to the demonstration of the 3DHD combination of Viking's cameras with Sony's 3DHD display by those who had the opportunity to experience it earlier this week in Singapore at Hospital Build Asia 2010 Exhibition and Congress.

14 May 2010

NiTi Surgical Solutions completes over 4,000 successful ColonRing applications in 16 countries

NiTi™ Surgical Solutions, an innovative surgical device company, today provided an update of sales and clinical data highlights related to its lead product ColonRing™, the first major advance in reconnection technology for gastrointestinal surgery in more than 30 years.

14 May 2010

Trubion Pharmaceuticals to present promising data from Phase 1 studies of SBI-087, SBI-087

Trubion Pharmaceuticals, Inc. today announced the acceptance of two Phase 1 data presentations on SBI-087 (PF-05230895) at the 2010 annual congress of the European League Against Rheumatism (EULAR) in Rome, Italy. Presentations will include promising data from a Phase 1 study of SBI-087 for the treatment of rheumatoid arthritis (RA) and a Phase 1 study of SBI-087 for the treatment of systemic lupus erythematosus (SLE). Copies of both abstracts are available at http://www.eular.org. SBI-087 is Trubion's next-generation CD20-directed small modular immunopharmaceutical (SMIP™) product candidate and is being developed in collaboration with Pfizer.

13 May 2010

Tripos releases SYBYL-X 1.1 molecular modeling suite

Tripos®, a leading provider of drug discovery informatics products and services, today announced the release and general availability of SYBYL-X Version 1.1. This new release focuses on enhancing research productivity for scientists in the pharmaceutical, agrochemical, flavors and fragrances, and related industries, featuring faster navigation, new menus and toolbars, and new ways to approach life science molecular discovery projects. Previous SYBYL versions have been the benchmark for the industry in molecular modeling, and customers using this new, next generation version have given it high marks.

13 May 2010

Carrot Medical, MAVIG execute global marketing and sales channel partnership agreement

Carrot Medical, a leading designer of integrated medical imaging display systems, and MAVIG GmbH, the leading manufacturer of medical imaging monitor suspension systems, announced today the execution of a global marketing and sales channel partnership agreement. This partnership provides a semi-exclusive contract for the sale of all products through MAVIG's global sales channel while offering MAVIG access to the next generation of integrated medical imaging display technology.

12 May 2010

Key mechanisms for delivery of LNP-encapsulated siRNAs to the liver

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the publication of pre-clinical research in the journal Molecular Therapy revealing key mechanisms related to the systemic delivery of RNAi therapeutics using lipid nanoparticles (LNPs).

12 May 2010

Researchers develop anti-angiogenic molecule SR16388 for treatment of MM

SRI International, an independent nonprofit research and development organization, announced today that researchers have developed an anti-angiogenic molecule SR16388 that has demonstrated preclinical antitumor activity against multiple myeloma.

12 May 2010

Oncos Therapeutics completes € 4 million investment from HealthCap

Oncos Therapeutics, a biotech company developing new cancer therapeutics based on its next generation oncolytic viruses, completed a € 4 million ($ 5.5 million) investment from HealthCap. With committed capital exceeding € 800 million, HealthCap is one of the largest specialized providers of venture capital within life sciences in Europe.

12 May 2010

LifeCodexx AG develops test using Next Generation Sequencing technologies for prenatal diagnostics

LifeCodexx AG has started operational research and development work on clinically validated diagnostic tests by using Next Generation Sequencing technologies. The work currently focuses on the field of prenatal diagnostics.

12 May 2010

Genmab reports revenues of DKK 107M for first-quarter 2010

Genmab's revenues were DKK 107 million (USD 19 million) for the first quarter of 2010. In the same period of 2009, Genmab recognized revenues of DKK 250 million (USD 45 million).

12 May 2010

Viking Systems to demonstrate 3DHD Vision System prototype at Hospital Build Asia 2010

Viking Systems, Inc. today announced that a prototype version of its Next Generation 3DHD Vision System will be demonstrated with Sony's prototype 3DHD Medical Display in Sony's booth at Hospital Build Asia 2010 which will run May 11 -13 in Singapore.

11 May 2010

Transition Therapeutics reports increased revenue in third-quarter 2010

Transition Therapeutics Inc., a product-focused biopharmaceutical company developing therapeutics for disease indications with large markets, today announced its financial results for the quarter ended March 31, 2010.

11 May 2010

Enzon reports income from continuing operations of $20.8M for first-quarter 2010

Enzon Pharmaceuticals, Inc. today announced its financial results for the first quarter of 2010. During the quarter, the Company completed the sale of its specialty pharmaceutical business. This transaction has now transformed the Company, both financially and operationally, into a biopharmaceutical company dedicated to the discovery and development of oncology medicines.

10 May 2010

Next Generation News and Research

PositiveID announces early completion of iGlucose system prototype development

Inovio Pharmaceuticals first-quarter net loss attributable to common stockholders decreases to $2.3M

Echo Therapeutics first-quarter net loss increases to $1.9 million

152 research and training grants awarded to researchers at 93 institutions nationwide

U.S. Patent and Trademark Office grants patent to Historx's AQUA technology

IVAX Diagnostics first-quarter net revenues decline 1.4% to $4,655,000

Rensselaer professor selected to receive NSF CAREER Award

Viking Systems announces positive response to 3DHD camera-display combination at Hospital Build Asia 2010

NiTi Surgical Solutions completes over 4,000 successful ColonRing applications in 16 countries

Trubion Pharmaceuticals to present promising data from Phase 1 studies of SBI-087, SBI-087

Tripos releases SYBYL-X 1.1 molecular modeling suite

Carrot Medical, MAVIG execute global marketing and sales channel partnership agreement

Key mechanisms for delivery of LNP-encapsulated siRNAs to the liver

Researchers develop anti-angiogenic molecule SR16388 for treatment of MM

Oncos Therapeutics completes € 4 million investment from HealthCap

LifeCodexx AG develops test using Next Generation Sequencing technologies for prenatal diagnostics

Genmab reports revenues of DKK 107M for first-quarter 2010

Viking Systems to demonstrate 3DHD Vision System prototype at Hospital Build Asia 2010

Transition Therapeutics reports increased revenue in third-quarter 2010

Enzon reports income from continuing operations of $20.8M for first-quarter 2010

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News